Will active ETFs threaten unit trusts?

Active ETFs can compete in many respects with unit trusts, writes Pedro van Gaalen

BL PREMIUM
TALKING TECHNICALS: Nasdaq 100 bullish, but …

As equity markets fret over global economy, lower highs could signal end of run

BL PREMIUM
Long4Life: Joffe’s project is still well worth watching

Long4Life is determined to make acquisitions and take equity interests in businesses with a track record of success and strong cash-flow

BL PREMIUM
Super Group: Growth, not dividends, tops this priority list

The transport conglomerate that has been a consistent performer in the past few years

BL PREMIUM
Alaris Holdings: Possible chance for a niche growth story

Tucked away on the JSE’s AltX board, this specialised counter first came to the market as Poynting Holdings, amid the euphoria of the 2007 listings boom

BL PREMIUM
Atlantic Leaf Properties: Catching the attention of more investors

The company is starting to appear on the radar of investors looking for a smaller-cap real-estate play with solid growth prospects

BL PREMIUM
Choppies: Investors nervous after share-price destruction

Choppies’ share price collapse will rekindle grim memories

BL PREMIUM
Looking at a trio of big names

From commodities to financial investment to luxury goods, these three giants have had varied fortunes over the past 12 months

BL PREMIUM
ANTHONY CLARK: Down but not out of contention

There is potential on these two shares — for those who can make the right judgment calls

BL PREMIUM
Acid test for asset managers

For the sake of shareholder capitalism’s future they must act like real owners, not just fee-earning agents, writes Ann Crotty

BL PREMIUM
Tracking Aspen’s troubles

Yes, there were signs of a dramatic fall in share price — but there is still hope, writes Nigel Dunn

BL PREMIUM
Trade of the Month: FTSE-JSE Financials Index vs rand/dollar

Uncertainty continues as international investors remain wary because of the issue of land expropriation without compensation

BL PREMIUM
Pick of the Month: Anglo American

It seems Anglo American is on track to provide investors with a solid return

BL PREMIUM
EDITOR’S NOTE: What’s worth a tilt in tough times?

With hindsight, Mediclinic probably did not strike the best deal terms, and this has come back to haunt Remgro

BL PREMIUM
What’s going on with resources?

Where is the commodities cycle going? How does this cycle differ from others? Experts see both new factors and the usual drivers, reports Lisa Steyn

BL PREMIUM
TALKING TECHNICALS: Wait for the pain to pass

Emerging market crises have typically offered buying opportunities for the long term

BL PREMIUM

Published by Tiso Blackstar and distributed with the Financial Mail on the last Thursday of every month except December and January.